Clinical Immunology of Viral Hepatitis, Myeloproliferative Neoplasms, and Stem Cell Transplantation
This community investigates the clinical management and immunological mechanisms of chronic viral hepatitis, myeloproliferative neoplasms, and complications arising from stem cell transplantation.
The research focuses heavily on hepatitis virus infections, particularly hepatitis B and C, and their treatment with interferon therapy. A significant strand addresses hematopoietic stem cell transplantation, including donor matching via minor histocompatibility antigens and the management of graft-versus-host disease. The community also examines specific hematological conditions such as polycythemia vera, alongside the role of T-cells and immune dysregulation in various infectious and autoimmune contexts. Recurring themes include the use of sodium taurocholate in hepatic studies and the clinical outcomes of cell transplantation procedures.
The community is most prominently featured in research tracked for sodium, where it represents a small but distinct share of the element's literature. It also appears in potassium and lead research, though with lower paper counts. Sodium contributes the highest number of papers within this group, with 52 entries, followed by potassium with 47 and lead with 40.
The community comprises 3,218 papers, published primarily in The Journal of Immunology, Blood, and JAMA: The Journal of the American Medical Association.
Recent work includes studies on HLA haplotype frequency analysis for stem cell donor recruitment in specific populations and the evaluation of viral T-cell response prediction using computational models. Other recent entries address the prognosis of malignant ovarian germ cell tumors and the clinical characteristics of NK/T-cell lymphomas with cardiac involvement.